We are live on ! Find out more

BSTG

Biostage, Inc. Common Stock

BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

51 hedge funds and large institutions have $31.1M invested in Biostage, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New

Increased

Maintained

Reduced

Closed

86% more capital invested

Capital invested by funds: $16.7M → $31.1M (+$14.4M)

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

4% less funds holding

Funds holding: 53 → 51 (-2)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders

Holders Change

-2

Holders Change %

-3.77%

% of All Funds

1.47%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	PM Penbrook Management New York	+$825K
2	PAIM Punch & Associates Investment Management Edina, Minnesota	+$728K
3	6CM 683 Capital Management New York	+$594K
4	Vanguard Group Malvern, Pennsylvania	+$230K
5	TC TFS Capital West Chester, Pennsylvania	+$138K

Top Sellers

Rank	Fund	Capital Flow
1	BIT BlackRock Institutional Trust San Francisco, California	-$473K
2	Fuller & Thaler Asset Management San Mateo, California	-$430K
3	Renaissance Technologies New York	-$336K
4	MOACM Mutual of America Capital Management New York	-$309K
5	JG Jefferies Group New York	-$238K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	BIM 26 BlackRock Investment Management Wilmington, Delaware	$199K	+$249	+42	+0.2%
27	GAG 27 GM Advisory Group Melville, New York	$186K	+$125K	+21,025	New
28	WIC 28 Woodmont Investment Counsel Nashville, Tennessee	$182K	–	–	–
29	BA 29 Bard Associates Chicago, Illinois	$170K	-$137K	-23,155	-55%
30	30 Two Sigma Investments New York	$111K	+$72.5K	+12,233	New
31	31 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$104K	–	–	–
32	TA 32 Teachers Advisors New York	$74K	–	–	–
33	TDC 33 Thompson Davis & Co Richmond, Virginia	$71K	-$97.8K	-16,505	-68%
34	BJ 34 BlackRock Japan Tokyo, Japan	$69K	-$2.8K	-472	-6%
35	NFA 35 Nationwide Fund Advisors Columbus, Ohio	$66K	–	–	–
36	CCA 36 Catalyst Capital Advisors Huntington, New York	$56K	–	–	–
37	AIG 37 American International Group New York	$39.7K	+$617	+104	+2%
38	38 Barclays London, United Kingdom	$24K	+$8.26K	+1,394	+109%
39	39 Deutsche Bank Frankfurt Am Main Ge, Germany	$24K	+$8.65K	+1,460	+120%
40	SO 40 STRS Ohio Columbus, Ohio	$22K	–	–	–
41	TRCT 41 Tower Research Capital (TRC) New York	$21K	+$13.5K	+2,282	New
42	42 Wells Fargo San Francisco, California	$14K	–	–	–
43	43 Citigroup New York	$9K	-$15.6K	-2,632	-72%
44	LTFS 44 Ladenburg Thalmann Financial Services Miami, Florida	$9K	+$5.29K	+893	+1,191%
45	45 Group One Trading Chicago, Illinois	$6K	-$27.5K	-4,633	-88%
46	U 46 UBS Zurich, Switzerland	$5K	-$12.4K	-2,096	-78%
47	47 Schroder Investment Management Group London, United Kingdom	$2.17K	–	–	–
48	CCMH 48 Cornerstone Capital Management Holdings New York	$1K	-$6.52K	-1,100	-90%
49	49 Fuller & Thaler Asset Management San Mateo, California	–	-$430K	-90,500	Closed
50	50 Renaissance Technologies New York	–	-$336K	-70,750	Closed

BSTG Hedge Fund Activity: Q1 2014 in Review

51 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q1 2014, worth a combined $31.1M — up 86% from $16.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BSTG and 7 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 14 added.

The largest buyer was Penbrook Management, adding an estimated $825K. The largest seller was BlackRock Institutional Trust, cutting an estimated $473K.

51 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q1 2014, down from 53 in Q4 2013.
Funds reported $31.1M of Biostage, Inc. Common Stock stock for Q1 2014, up 86% quarter-over-quarter.
7 funds opened new Biostage, Inc. Common Stock positions in Q1 2014 and 9 closed out, a net change of -2 holders.
The largest Biostage, Inc. Common Stock buyer in Q1 2014 was Penbrook Management, an estimated $825K added.
The largest Biostage, Inc. Common Stock seller in Q1 2014 was BlackRock Institutional Trust, an estimated $473K sold.

Based on aggregated 13F filings for Q1 2014.

Biostage, Inc. Common Stock BSTG